Table 3.
Univariate analysis of factors associated with SARS-CoV-2 telemedicine care offers (n = 271).
Aspect | Value | Conversion to telemedicine care accepted |
χ2 | p-Value⁎ | ||
---|---|---|---|---|---|---|
Yes | No | Sum | ||||
Gender | Female | 71 | 79 | 150 | 7.067 | 0.024 |
Male | 38 | 83 | 121 | |||
Epilepsy severity | Active | 83 | 124 | 207 | 0.098 | 0.875 |
Remission | 20 | 33 | 53 | |||
Subjective SARS-CoV-2 threat | High | 56 | 51 | 107 | 14.103 | 0.004 |
Low | 40 | 99 | 139 | |||
Age | < 45 years | 76 | 104 | 180 | 1.155 | 0.374 |
≥ 45 years | 30 | 55 | 85 | |||
Living environment | Urban | 46 | 73 | 119 | 0.14 | 0.709 |
Rural | 61 | 88 | 149 | |||
Subjective appointment urgency | At least urgent | 67 | 12 | 97 | 96.783 | 0.004 |
Less/nonurgent | 37 | 147 | 184 | |||
Epilepsy type | Focal | 84 | 90 | 174 | 2.007 | 0.178 |
Generalized | 16 | 28 | 44 | |||
Seizure type | Only focal | 25 | 35 | 60 | 0.054 | 0.881 |
Generalized | 82 | 123 | 205 |
p-Values after two-tailed Pearson's chi-squared and post hoc correction on difference between the expected frequencies and the observed frequencies of the mentioned aspect within the cohort, corrected for multiple testing after Benjamini–Hochberg (bold figures represent significant findings).